Pharmaceutical company Bu Xiang (603858.SH) plans to transfer the controlling stake of its subsidiary to develop and integrate the large health industry.

Intelligence Finance APP News, Changsheng Pharmaceutical (603858.SH) announced that in order to vigorously develop and integrate the company's health industry, the company plans to transfer 1% equity of 9 holding subsidiaries (Ningbo Chang Trading, Shandong Chang Cosmetics, Shandong Chang Ding Sheng, Shandong Chang Chuan Fang, Shandong Chang Youpin, Jinan Chang Chicheng, Jinan Chang Gaigan, Jinan Chang Yixi, Jinan Chang Zhongfu) held by the company to Xie Jihui.